
About Hyundai Pharm
Hyundai Pharm is a publicly listed company based in Seoul (South Korea) founded in 1965. Pharmaceuticals and consumer health products are manufactured and marketed. The company has 401 employees. Its website hyundaipharm.co.kr draws about 26 thousand monthly visits. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation.
Company details
Founded in 1965 and headquartered in Seoul, South Korea, operations are centered on the pharmaceuticals and consumer health sector. A diverse portfolio of products is developed and marketed, covering therapeutic areas such as over-the-counter medications, energy drinks, and hair care solutions. Innovation is pursued through new product launches and line expansions. Corporate social responsibility is addressed via initiatives like sponsorship of cultural events.
- Headquarters Seoul, South Korea
- Employees 401
- Stage Public
- SectorsHealthcare
- Website hyundaipharm.co.kr
- Social LinkedIn X
- Legal Name Hyundai Pharmaceutical Co., Ltd.
- Annual Revenue$130.5 M (USD)9.14as on Nov 30, 2025
- Net Profit$1.71 M (USD)as on Nov 30, 2025
- EBITDA$5.16 M (USD)95.89as on Nov 30, 2025
- Employee Count401
IPO & Listings of Hyundai Pharm
Hyundai Pharm is a publicly listed company on the KRX with ticker symbol 004310 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date28 Jun 1978
- Listed onKRX: 004310
- Listed entityHyundai Pharmaceutical Co., Ltd.
- Exchange sectorHealth technology
- ISINKR7004310009
- Share price7,580.00 KRW (-0.66% on the day) · 2026-10-14
- Market capitalisation235,891,760,559.00 KRW
- Price to earnings46.6
- EPS (diluted, trailing year)162.83 KRW
- Dividend yield0.39%
- Volume (last session)407,544
Financials of Hyundai Pharm
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 191.79B KRW | 2.52B KRW | 7.58B KRW |
| 2024 | 175.74B KRW | -574.9M KRW | 3.87B KRW |
| 2023 | 180.76B KRW | 6.12B KRW | 10.23B KRW |
| 2022 | 162.69B KRW | -164.6M KRW | 11.27B KRW |
| 2021 | 139.80B KRW | -3.17B KRW | 2.41B KRW |
Detailed financial statements for Hyundai Pharm
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Hyundai Pharm
The website of Hyundai Pharm (hyundaipharm.co.kr) receives about 25.8K visits a month.
- Monthly visits25.8K
▼ 0.5% vs previous month
Websites whose visitors overlap most with Hyundai Pharm. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| dongsung-pharm.com | 100% | 22.7K | #1,423,529 | View details | |
| choa.co.kr | 79% | 14K | #1,738,079 | View details | |
| health.kr | 56% | #14,868 | View details | ||
| mmpharm.co.kr | 48% | 25.5K | #769,589 | View details | |
| daedamo.com | 48% | 680.7K | #100,922 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for Hyundai Pharm
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Hyundai Pharm
Complete news archive for Hyundai Pharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hyundai Pharm
Hyundai Pharm was founded in 1965.
Hyundai Pharm is headquartered in Seoul, South Korea.
Hyundai Pharm has 401 employees.
Annual revenue of Hyundai Pharm is $130.5M as on Nov 30, 2025.
Founded in 1965 and headquartered in Seoul, South Korea, operations are centered on the pharmaceuticals and consumer health sector. A diverse portfolio of products is developed and marketed, covering therapeutic areas such as over-the-counter medications, energy drinks, and hair care solutions. Innovation is pursued through new product launches and line expansions. Corporate social responsibility is addressed via initiatives like sponsorship of cultural events.
Yes, Hyundai Pharm is publicly traded on KRX under the ticker symbol 004310.
